Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-Marketing Clinical Study of Aricept in Patients With Dementia With Lewy Bodies (DLB)

NCT02345213 is registered in ClinicalTrials.gov with Eisai Co., Ltd. as lead sponsor.

NCT NCT02345213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02345213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-Marketing Clinical Study of Aricept in Patients With Dementia With Lewy Bodies (DLB)
Lead sponsor
Eisai Co., Ltd.
Phase
Phase 4
Overall status
Completed
Start date
March 1, 2015
Completion date
March 26, 2018
Enrollment
160 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dementia, lewy body, lewy body disease